79 related articles for article (PubMed ID: 1971568)
1. Selective inactivation by chlorofluoroacetamides of the major phenobarbital-inducible form(s) of rat liver cytochrome P-450.
Halpert J; Jaw JY; Balfour C; Kaminsky LS
Drug Metab Dispos; 1990; 18(2):168-74. PubMed ID: 1971568
[TBL] [Abstract][Full Text] [Related]
2. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
Stevens JC; Halpert J
Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices.
Poet TS; Brendel K; Halpert JR
Toxicol Appl Pharmacol; 1994 May; 126(1):26-32. PubMed ID: 8184429
[TBL] [Abstract][Full Text] [Related]
4. Dichloromethyl compounds as mechanism-based inactivators of rat liver cytochromes P-450 in vitro.
Halpert JR; Balfour C; Miller NE; Kaminsky LS
Mol Pharmacol; 1986 Jul; 30(1):19-24. PubMed ID: 3724741
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
Miller NE; Halpert JR
Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
[TBL] [Abstract][Full Text] [Related]
6. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
Ciaccio PJ; Duignan DB; Halpert JR
Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713
[TBL] [Abstract][Full Text] [Related]
7. Selective inactivation of rat liver cytochromes P-450 by 21-chlorinated steroids.
Halpert J; Jaw JY; Cornfield LJ; Balfour C; Mash EA
Drug Metab Dispos; 1989; 17(1):26-31. PubMed ID: 2566465
[TBL] [Abstract][Full Text] [Related]
8. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
Halpert J; Balfour C; Miller NE; Morgan ET; Dunbar D; Kaminsky LS
Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
Ng SF; Waxman DJ
Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
[TBL] [Abstract][Full Text] [Related]
10. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
12. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
[TBL] [Abstract][Full Text] [Related]
13. Induction of rat hepatic cytochrome P450 2B subfamily by azidophenobarbital, as a possible photoaffinity probe for the putative phenobarbital receptor: comparative study with modified phenobarbitals with different functional groups.
Shinohara T; Taura Ki; Imamura T; Yamada H; Oguri K
Drug Metab Dispos; 1997 Dec; 25(12):1442-6. PubMed ID: 9394036
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
15. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for a functionally unique cytochrome P450IIB1 variant.
Kedzie KM; Balfour CA; Escobar GY; Grimm SW; He YA; Pepperl DJ; Regan JW; Stevens JC; Halpert JR
J Biol Chem; 1991 Nov; 266(33):22515-21. PubMed ID: 1718996
[TBL] [Abstract][Full Text] [Related]
17. Effect of ovariectomy and androgen on phenobarbital induction of hepatic CYP2B1 and CYP2B2 in Sprague-Dawley rats.
Chang TK; Anderson MD; Bandiera SM; Bellward GD
Drug Metab Dispos; 1997 Aug; 25(8):994-1000. PubMed ID: 9280408
[TBL] [Abstract][Full Text] [Related]
18. Ring hydroxylation of [o-3H]methoxychlor as a probe for liver microsomal CYP2B activity: potential for in vivo CYP2B assay.
Stresser DM; Dehal SS; Kupfer D
Anal Biochem; 1996 Jan; 233(1):100-7. PubMed ID: 8789153
[TBL] [Abstract][Full Text] [Related]
19. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
Okita RT; Masters BS
Drug Metab Dispos; 1980; 8(3):147-51. PubMed ID: 6104577
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes.
Shiverick KT
Drug Metab Dispos; 1981; 9(6):545-50. PubMed ID: 6120814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
